TY - JOUR T1 - Genomic analyses of human adenoviruses unravel novel recombinant genotypes associated with severe infections in pediatric patients JF - medRxiv DO - 10.1101/2021.08.01.21261368 SP - 2021.08.01.21261368 AU - Joyce Odeke Akello AU - Richard Kamgang AU - Maria Teresa Barbani AU - Franziska Suter-Riniker AU - Christoph Aebi AU - Christian Beuret AU - Daniel H. Paris AU - Stephen L Leib AU - Alban Ramette Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/02/2021.08.01.21261368.abstract N2 - Background Human Adenoviruses (HAdVs) are highly contagious pathogens of clinical importance, especially among the pediatric population. Studies on comparative viral genomic analysis of cases associated with severe and mild infections due to HAdV are limited. Using whole-genome sequencing (WGS), we investigated whether there were any differences between circulating HAdV strains associated with severe infections (meningitis, sepsis, convulsion, sudden infant death syndrome, death, and hospitalization) and mild clinical presentations in pediatric patients hospitalized between the years 1998 and 2017 in a tertiary care hospital group in Bern, Switzerland covering a population base of approx. 2 million inhabitants. The HAdV species implicated in causing severe infections in this study included HAdV species C genotypes (HAdV1, HAdV2, and HAdV5). Clustering of the HAdV whole-genome sequences of the severe and mild cases did not show any differences except for one sample (isolated from a patient presenting with sepsis, meningitis, and hospitalization) that formed its own cluster with HAdV species C genotypes. This isolate showed intertypic recombination events involving four genotypes, had the highest homology to HAdV89 at complete genome level, but possessed the fiber gene of HAdV1, thereby representing a novel genotype of HAdV species C. The incidence of potential recombination events was higher in severe cases than in mild cases. Our findings confirm that recombination among HAdVs is important for molecular evolution and emergence of new strains. Therefore, further research on HAdVs, particularly among susceptible groups, is needed and continuous surveillance is required for public health preparedness including outbreak investigations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from European Union Horizon 2020 research and innovation programme under the Marie actions grant agreement number 721367 (HONOURs)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Swiss Ethics Committees on Research involving humans (BASEC-Nr:Req-2018-00158)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenome sequences for all 14 isolates are deposited to the European Nucleotide Archive, under project reference PRJEB40708 ER -